🇧🇭Bahrain Active

NHRA-MVC Traceability Hub National Health Regulatory Authority
Serialization Requirements
Level Required Identifier Type Description
Unit Required SGTIN GS1-compliant Data Matrix with GTIN
Case/Bundle Required SSCC Case-level aggregation mandatory
Pallet/Shipper Required SSCC Pallet aggregation mandatory
Reporting Obligations
Event Type Required Timing Description
Commissioning Required Before shipment Serial generation and EPCIS reporting to NHRA-MVC Hub
Shipping Required At shipment Dispatch event
Receiving Required Upon receipt Receipt event
Authentication Required Real-time Scanning and authentication by customs, distributors, pharmacies
Technical Requirements
EPCIS Version
v@Model.TechnicalRequirements.EpcisVersion
Data Format
XML
Integration Method
API
Barcode Type
DataMatrix (GS1)
Required Fields
GTIN Serial Number Batch/Lot Expiry Date
Product Scope
  • Prescription pharmaceutical products
  • Vaccines
  • Biological products
  • OTC medicines (from 2026)
Official Documents
View All
Guideline
NHRA-MVC Guidelines
NHRA View
TechnicalSpec
NHRA Serialization Technical Requirements
NHRA View
Key Deadlines
Legislative Decree No. 41
Jan 01, 2017
Legislative framework for pharmaceutical track-and-trace
Phase 1 - Serialization & EPCIS
Dec 31, 2021
Serialization and EPCIS reporting to NHRA-MVC Hub (MAHs)
Phase 2 - Aggregation
May 01, 2022
Mandatory aggregation to cases and pallets (MAHs)
Phase 3 - Full Authentication
Jun 01, 2022
Scanning and authentication by customs, distributors, pharmacies
Phase 4 - Prescription Medicines
Jan 01, 2025
Serialization mandatory for all prescription medicines
Phase 5 - OTC Extension
Jan 01, 2026
Aggregation and reporting extended to OTC medicines
Notes

NHRA-MVC is a blockchain-based end-to-end traceability hub - first of its kind in the GCC. System upgraded in January 2025 with enhanced capabilities. Labels must be in English and Arabic. Real-time product verification available for stakeholders.

Last updated: December 25, 2024